Cholinergic deficiency frontal dysfunction Parkinson disease influence central cholinergic deficit cognitive function Parkinson disease PD neuropsychological performance group patients anticholinergic drugs mean mg group patients anticholinergics groups variables parkinsonism levodopa therapy dose significant difference groups patients intellectual visuospatial instrumental memory function contrast group anticholinergics severe impairment tests frontal lobe function results lesion cholinergic neurons post mortem PD role subcorticofrontal behavioral impairment disease 